Annual Meeting Abstract Submission
The American College of Rheumatology and Association of Rheumatology Professionals invite you to submit an abstract to ACR Convergence and take advantage of the opportunity to have your work peer reviewed by experts in the field.
Abstract submission is closed. Notification of abstract acceptance will be sent in late August.
Late-breaking abstract submission opens September 5.
Abstract Submission Eligibility
Persons Eligible to Submit
- Members and non-members of the ACR and ARP are eligible to submit an abstract.
- Employees or owners of ineligible companies may be the presenting author of an abstract in the concurrent oral and poster abstract programs.
- To be eligible for plenary consideration, no listed authors of an abstract may be owners/employees of an ineligible company.
Abstracts Eligible for Submission
- Abstracts that have been previously accepted and/or presented at other medical meetings are eligible for submission. These abstracts will go through the same peer review process as any other abstracts.
- Abstracts describing original basic and clinical science related to the broad area of rheumatic diseases may be submitted.
- Abstracts reporting results of a clinical trial will be required to identify the trial phase.
- Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association.
Abstracts Not Eligible for Submission
- Abstracts should not report results that have been previously presented at an ACR/ARP annual meeting.
- Abstracts that report work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the submission deadline of noon ET on Thursday, June 8, 2023, are ineligible for consideration.
- Multiple abstracts may not be submitted for one study unless substantially different research questions are being addressed in each abstract.
- Abstracts submitted for the ARP program may not be concurrently submitted to the ACR program.
- Case reports are not considered appropriate and will not be reviewed. We encourage those with interesting cases or images to consider submission to the Thieves Market, Image Competition or Global Rheumatology Summit. See separate submission processes.
- Abstracts not accepted in the main abstract review submission should not be re-submitted to the late-breaking category.
Abstract Submission Guidelines
Please read the complete Call for Abstracts Guidelines prior to submitting.
Abstract Submission Timeline
The abstract submission deadline is June 8, at noon ET. Notifications will be sent in late August.
Prior to notification of acceptance:
- After noon ET on Thursday, June 8, presenting authors may submit a request to have an abstract withdrawn
- All requests for withdrawal can only be made by the presenting author and must be submitted via email to: email@example.com
- Withdrawal requests must include the following:
- Abstract ID Number
- Abstract Title
- Presenting Author's Name
After notification of acceptance:
- A link at which to accept the invitation to present will be sent to the presenting author. If the author declines the invitation, the abstract will be withdrawn.
Removal of a withdrawn abstract from the online supplement of Arthritis & Rheumatology cannot be guaranteed if the request is received after Monday, August 28. However, the abstract can still be removed from appearing in the ACR Convergence online program after that date.